Published in N Engl J Med on May 18, 1989
A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood (1993) 2.29
Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis. Cytokine (2008) 1.95
The colony-stimulating factors and cancer. Nat Rev Cancer (2010) 1.44
Thyrotoxicosis and antithyroid drugs. Postgrad Med J (1997) 1.38
Dynamic hematological disease: a review. J Math Biol (2008) 1.08
Neutrophil disorders and their management. J Clin Pathol (2001) 1.03
G-CSF influences mouse skeletal muscle development and regeneration by stimulating myoblast proliferation. J Exp Med (2011) 1.02
G-CSF and GM-CSF in Neutropenia. J Immunol (2015) 0.98
The investigation and management of chronic neutropenia in children. Arch Dis Child (2006) 0.97
Severe neutropenia: a diagnostic approach. West J Med (2000) 0.95
Cyclic neutropenia and severe congenital neutropenia in patients with a shared ELANE mutation and paternal haplotype: evidence for phenotype determination by modifying genes. Pediatr Blood Cancer (2010) 0.94
Progenitor cell self-renewal and cyclic neutropenia. Cell Prolif (2009) 0.84
Stability of a model of human granulopoiesis using continuous maturation. J Math Biol (2004) 0.82
Paradoxical drop in circulating neutrophil count following granulocyte-colony stimulating factor and stem cell factor administration in rhesus macaques. Exp Hematol (2007) 0.81
Angiotensin II increases host resistance to peritonitis. Clin Diagn Lab Immunol (2000) 0.80
Understanding, treating and avoiding hematological disease: better medicine through mathematics? Bull Math Biol (2014) 0.77
Haemopoietic growth factors. Postgrad Med J (1997) 0.77
Leukocyte integrin activation mediates transient neutropenia after G-CSF administration. Blood (2011) 0.76
[Periodic fever syndromes]. Z Rheumatol (2006) 0.76
Allogeneic Transplant in ELANE and MEFV Mutation Positive Severe Cyclic Neutropenia: Review of Prognostic Factors for Secondary Severe Events. Case Rep Hematol (2017) 0.75
G-CSF and GM-CSF in clinical trials. Yale J Biol Med (1991) 0.75
The Jeremiah Metzger lecture. Regulation of hematopoiesis. Trans Am Clin Climatol Assoc (1990) 0.75
A case of systemic amyloidosis associated with cyclic neutropenia. Pediatr Nephrol (2010) 0.75
The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) (1975) 9.01
Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med (1976) 5.16
The effect of in vivo hydrocortisone on subpopulations of human lymphocytes. J Clin Invest (1974) 4.90
Differential expression of the amv gene in human hematopoietic cells. Proc Natl Acad Sci U S A (1982) 4.37
Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science (1986) 3.92
Definition of a common leukocyte cell-surface antigen (Lp95-150) associated with diverse cell-mediated immune functions. J Immunol (1983) 3.70
The role of neutrophil membrane glycoprotein GP-150 in neutrophil adherence to endothelium in vitro. Blood (1985) 3.53
Elevated temperature incubation of enrichment media for the isolation of salmonellas from heavily contaminated materials. J Hyg (Lond) (1968) 2.77
Cellular sequences are present in the presumptive avian myeloblastosis virus genome. Proc Natl Acad Sci U S A (1980) 2.45
Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat Genet (1999) 2.38
Colchicine therapy for familial mediterranean fever. A double-blind trial. N Engl J Med (1974) 2.35
Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet (1988) 2.28
Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates. J Exp Med (1987) 2.17
Frequency of immediate adverse effects associated with therapeutic apheresis. Transfusion (1999) 2.17
Wegener's granulomatosis. Ann Intern Med (1974) 2.13
Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med (1989) 2.13
Studies of the human c-myb gene and its product in human acute leukemias. Science (1986) 2.10
Alternate-day prednisone therapy and human lymphocyte subpopulations. J Clin Invest (1975) 2.10
The examination of samples infected with multiple salmonella serotypes. J Hyg (Lond) (1967) 2.04
Thyroid storm presenting as congestive heart failure and protein-S deficiency-induced biventricular and internal jugular venous thrombii. J Postgrad Med (2013) 2.04
Severe recurrent bacterial infections associated with defective adherence and chemotaxis in two patients with neutrophils deficient in a cell-associated glycoprotein. J Pediatr (1982) 2.03
Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer (1987) 1.97
Neutrophil transfusions: kinetics and functions of neutrophils mobilized with granulocyte-colony-stimulating factor and dexamethasone. Transfusion (1998) 1.83
Alternate-day prednisone. Leukocyte kinetics and susceptibility to infections. N Engl J Med (1974) 1.80
Cyclical neutropenia and other periodic hematological disorders: a review of mechanisms and mathematical models. Blood (1998) 1.79
Factitious fever and self-induced infection: a report of 32 cases and review of the literature. Ann Intern Med (1979) 1.73
Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood (1996) 1.72
Comparison of selenite F, Muller-Kauffmann tetrathionate and Rappaport's medium for the isolation of salmonellas from sewage-polluted natural water using a pre-enrichment technique. J Hyg (Lond) (1979) 1.65
Studies of the putative transforming protein of the type I human T-cell leukemia virus. Science (1985) 1.65
Absence of monoclonal-antibody-defined protein complex in boy with abnormal leucocyte function. Lancet (1984) 1.63
Identification and characterization of the protein encoded by the human N-myc oncogene. Science (1986) 1.58
The effect of Hydrocortisone on the kinetics of normal human lymphocytes. Blood (1975) 1.57
Vertebrate DNAs contain nucleotide sequences related to the transforming gene of avian myeloblastosis virus. J Virol (1981) 1.57
Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. Blood (2000) 1.54
Stimulation of immunoglobulin secretion in human B lymphocytes as a direct effect of high concentrations of IL 2. J Immunol (1984) 1.54
Current status of granulocyte (neutrophil) transfusion therapy for infectious diseases. J Infect Dis (2000) 1.53
Glucocorticoids inhibit apoptosis of human neutrophils. Blood (1995) 1.50
In vivo stimulation of granulopoiesis by recombinant human granulocyte colony-stimulating factor. Proc Natl Acad Sci U S A (1987) 1.50
Frequency of immediate adverse effects associated with apheresis donation. Transfusion (1998) 1.49
Granulocyte colony-stimulating factor enhances interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci U S A (1988) 1.49
A method of secondary enrichment for salmonellas independent of selectively toxic chemicals. J Hyg (Lond) (1966) 1.49
Salmonellas of subgenus 3 (Arizona) isolated from abattoirs in England and Wales. J Hyg (Lond) (1966) 1.49
Lactoferrin--specific localization in the nuclei of human polymorphonuclear neutrophilic leukocytes. Proc Soc Exp Biol Med (1971) 1.47
A new medium for isolating Campylobacter jejuni/coli. J Clin Pathol (1982) 1.46
Identification of a proviral genome associated with avian myeloblastic leukemia. Proc Natl Acad Sci U S A (1980) 1.39
Human immunodeficiency virus type 1 Vpr interacts with HHR23A, a cellular protein implicated in nucleotide excision DNA repair. J Virol (1997) 1.37
The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood (1993) 1.36
Effect of prophylactic colchicine therapy on leukocyte function in patients with familial Mediterranean fever. Arthritis Rheum (1976) 1.36
Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group. Oncogene (1995) 1.34
Studies on the isolation of Salmonella dublin. J Hyg (Lond) (1975) 1.34
Neutrophil-endothelial cell interactions on endothelial monolayers grown on micropore filters. J Clin Invest (1981) 1.34
Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy. Blood (1989) 1.33
Observations on environmental contamination in a microbiological laboratory. J Hyg (Lond) (1976) 1.32
Comparison of agents producing a neutrophilic leukocytosis in man. Hydrocortisone, prednisone, endotoxin, and etiocholanolone. J Clin Invest (1975) 1.32
Identification of the avian myeloblastosis virus genome. II. Restriction endonuclease analysis of DNA from lambda proviral recombinants and leukemic myeoblast clones. J Virol (1980) 1.31
Quality control tests of two salmonella enrichment media using different inocula. J Hyg (Lond) (1975) 1.28
Recombinant human granulocyte colony stimulating factor: molecular and biological characterization. Immunobiology (1986) 1.26
Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells. Proc Natl Acad Sci U S A (1996) 1.24
A pharmacokinetic-pharmacodynamic model for the mobilization of CD34+ hematopoietic progenitor cells by AMD3100. Clin Pharmacol Ther (2005) 1.24
Cyclic hematopoiesis: the mechanism of cyclic neutropenia in grey collie dogs. J Clin Invest (1972) 1.23
Gentamicin sulfate pharmacokinetics: lower levels of gentamicin in blood during fever. J Infect Dis (1975) 1.22
Sewer and drain swabbing as a means of investigating salmonellosis. J Hyg (Lond) (1970) 1.22
Characterization of avian myeloblastosis-associated virus DNA intermediates. J Virol (1980) 1.22
Myeloid cell kinetics in mice treated with recombinant interleukin-3, granulocyte colony-stimulating factor (CSF), or granulocyte-macrophage CSF in vivo. Blood (1991) 1.21
Identification of the avian myeloblastosis virus genome. I. Identification of restriction endonuclease fragments associated with acute myeloblastic leukemia. J Virol (1980) 1.21
Nucleotide sequence analysis of the long terminal repeat of avian myeloblastosis virus and adjacent host sequences. J Virol (1982) 1.21
Corticosteroids and infectious diseases. Med Clin North Am (1973) 1.17
Recombinant human granulocyte colony-stimulating factor enhances superoxide release in human granulocytes stimulated by the chemotactic peptide. Biochem Biophys Res Commun (1987) 1.16
Periodic hematopoiesis in human cyclic neutropenia. J Clin Invest (1973) 1.15
Subnuclear localization of the trans-activating protein of human T-cell leukemia virus type I. J Virol (1988) 1.15
In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients. Br J Cancer (1988) 1.14
Eosinophil kinetics in the hypereosinophilic syndrome. J Lab Clin Med (1976) 1.13
Studies of diarrheal disease in Central America. XI. Intestinal bacterial flora in malnourished children with shigellosis. Am J Trop Med Hyg (1968) 1.13
Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Leukemia (1997) 1.10
Studies of neutrophil production and turnover in grey collie dogs with cyclic neutropenia. J Clin Invest (1972) 1.10
Human cyclic neutropenia: clinical review and long-term follow-up of patients. Medicine (Baltimore) (1981) 1.10
Salmonella isolation with Rappaport's medium after pre-enrichment in buffered peptone water using a series of inoculum ratios. J Hyg (Lond) (1980) 1.09
A comparative trial of granulocyte-colony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers. Transfusion (1997) 1.09
Autoimmune neutropenia in systemic lupus erythematosus. Arthritis Rheum (1978) 1.09
Myelokathexis, a congenital disorder of severe neutropenia characterized by accelerated apoptosis and defective expression of bcl-x in neutrophil precursors. Blood (2000) 1.08
Observations on pre-enrichment for isolating salmonellas from sewage polluted natural water using Muller-Kauffmann tetrathionate broth prepared with fresh and desiccated ox bile. J Appl Bacteriol (1977) 1.07
Salmonellas in sewage. A study in latent human infection. J Hyg (Lond) (1969) 1.07
The impact of the granulocyte colony-stimulating factor on chemotherapy dose intensity and cancer survival: a systematic review and meta-analysis of randomized controlled trials. Ann Oncol (2013) 1.06
Universal WBC reduction. Transfusion (2000) 1.06
Principles of salmonella isolation. J Appl Bacteriol (1979) 1.06
Skin window studies of the acute inflammatory responses of neutropenic patients. Blood (1971) 1.04
Administration of interleukin-6 stimulates multilineage hematopoiesis and accelerates recovery from radiation-induced hematopoietic depression. Blood (1991) 1.04
Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood (2000) 1.03
Postirradiation treatment with granulocyte colony-stimulating factor and preirradiation WR-2721 administration synergize to enhance hemopoietic reconstitution and increase survival. Int J Radiat Oncol Biol Phys (1992) 1.02
Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens. J Infect Dis (1997) 1.02
Predeposited autologous blood for elective surgery. A national multicenter study. N Engl J Med (1987) 1.01
Isolations of subgenus 3 salmonellas (arizonas) in Cardiff, 1959-1971. J Hyg (Lond) (1973) 1.01
Comparison of selenite F, Muller-Kauffmann tetrathionate and Rappaport's medium for salmonella isolation from chicken giblets after pre-enrichment in buffered peptone water. J Hyg (Lond) (1981) 1.01